Topical Insulin Eye Drops: Stability and Safety of Two Compounded Formulations for Treating Persistent Corneal Epithelial Defects

• Príomhchruthaitheoirí: Marta Vicario- (Údar), Virginia Puebla-García (Údar), Lidia Ybañez-García (Údar), José Javier López-Cano (Údar), Miriam Ana González- (Údar), Marco Brugnera (Údar), Bárbara Burgos-Blasco (Údar), David Díaz-Valle (Údar), José Antonio Gegúndez-Fernández (Údar), José Manuel Benítez- (Údar), Rocío Herrero-Vanrell (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2024-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Compounded insulin eye drops were prepared at 1 IU/mL from commercially available subcutaneous insulin by dilution in saline solution or artificial tears. Physicochemical characterization and in vitro tolerance testing in human and conjunctival cells were followed by a 28-day short-term stability st...